622 related articles for article (PubMed ID: 16885372)
1. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
2. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
3. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
4. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
[TBL] [Abstract][Full Text] [Related]
5. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
[TBL] [Abstract][Full Text] [Related]
6. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
[TBL] [Abstract][Full Text] [Related]
7. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
8. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM
J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289
[TBL] [Abstract][Full Text] [Related]
10. A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson SC; Scott KA; Wilson JL; Thompson RG; Proudfoot AE; Balkwill FR
Cancer Res; 2003 Dec; 63(23):8360-5. PubMed ID: 14678997
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
13. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.
Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E
Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
16. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.
Ma X; Norsworthy K; Kundu N; Rodgers WH; Gimotty PA; Goloubeva O; Lipsky M; Li Y; Holt D; Fulton A
Mol Cancer Ther; 2009 Mar; 8(3):490-8. PubMed ID: 19276169
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.
Wendel M; Galani IE; Suri-Payer E; Cerwenka A
Cancer Res; 2008 Oct; 68(20):8437-45. PubMed ID: 18922917
[TBL] [Abstract][Full Text] [Related]
18. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
Welch DR; Aeed PA; Earhart RH; McClure SA
Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
20. ErbB3-dependent motility and intravasation in breast cancer metastasis.
Xue C; Liang F; Mahmood R; Vuolo M; Wyckoff J; Qian H; Tsai KL; Kim M; Locker J; Zhang ZY; Segall JE
Cancer Res; 2006 Feb; 66(3):1418-26. PubMed ID: 16452197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]